dave asprey bpc-157 Father of Biohacking" on Losing $26M, Getting Kicked Out of Your Own Company and Spotting Narcissists in Business - The Failure Factor Dave Asprey's Peptide Stack
Description
(2013) used statistical modeling to identify a single change point at which the relation between plasma methylmalonic acid and serum B12 changes slope to differentiate between inadequate and adequate B12 status
Use may result in positive drug tests, sanctions, and disqualification from competition
The evening BPC-157 dose follows roughly 2 hours post-game
This section digs into the four major degradation pathways that affect reconstituted peptides
IL-6 was measured in the DRG and SC tissues during phase 1
